Abstract
Objectives: 1. To compare growth parameters of patients with Congenital Adrenal Hyperplasia (CAH) managed on Prednisolone (PR) before and on Hydrocortisone (HC) after its availability in India. 2. To compare growth parameters of patients with CAH who have been on treatment with HC since diagnosis with patients managed on PR.Methods: Growth parameters of twelve children (8 m, 4f) with congenital adrenal hyperplasia were retrospectively studied while on treatment with prednisolone (PR) earlier and then hydrocortisone (HC) after it became freely available in India.Results: Patients treated with PR had height Z score of -0.42, weight Z score of -0.45, and height velocity Z score of -2.06. On HC these scores were -0.27, +0.16 and + 2.27. Patients treated with HC from the begining had a height Z Score of + 0.08, weight Z score of +0.22, and height velocity Z score of +0.68.Conclusion : Hydrocortisone has a less growth effect than prednisolone and patients treated with HC from the beginning showed near normal growth
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Raghupathy P. Disorders of Adrenocortical Biosynthesis. In Desai MP, Bhatia V, Menon PS, eds.Pediatric Endocrine Disorders, 1st edn. Chennai, Orient Longman, 2001; 215–228.
Agarwal DK, Agarwal KN, Upadhyay SK, Mittal R, Prakash R, Rai S. Physical and sexual growth pattern of affluent Indian children from 5–18 years of age.Indian Pediatr 1992; 29: 1203–1282.
Agarwal DK, Agarwal KN. Physical growth in Indian affluent children (Birth — 6 years).Indian Pediatr 1994; 31: 377–413.
Tanner JM, Whitehouse RH, Takaishi M. Standards from birth to maturity for height, weight, height velocity and weight velocity: British children 1965.Arch Dis Child 1966; 41: 454–71.
Huma Z, Crawford C, New MI. Congenital Adrenal Hyperplasia. In Brook CGD, ed.Clinical Pediatric Endocrinology, 3rd edn. London, Blackwell Science, 1995; pp 536–557.
DiMartino-Nardi J, Stoner E, O’Connell A, New MI. The effect of treatment on final height in classical congenital adrenal hyperplasia.Acta Endocrinol Suppl 1986, 279: 305–314.
Stikkelbroeck NM, Van’t Hof-Grootenboer, Hermus AR, Otten BJ, Van’t Hof MA. Growth inhibition by glucocorticoid treatment in salt wasting 21-hydroxylase deficiency: in early infancy and (pre)puberty.J Clin Endocrinol Metab 2003; 88: 3525–3530.
Haynes RC, Murad F. Adrenocoticotrophic hormone, Adrenocortical steroids and their synthetic analogues, Inhibitors of Adrenocortical steroid biosynthesis. In Goodman LS, Gilman A, Mayer SE, Melmon LK, eds.The Pharmacological Basis of Therapeutics, 6th edn. New York, McMillan Publishing Co. Inc. 1975; 1466–1496.
Punthakee Z, Legault L, Polychronalos C. Prednisolone in the treatment of adrenal insufficiency: a re-evaluation of relative potency.J Pediatr 2003; 143: 402–405.
Einaudi S, Lala R, Corrias A, Matarazzo P, Pagliardini S, Sanctis C. Auxological and biochemical parameters in assessing treatment of infants and toddlers with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.J Pediatr Endocrinol 1993; 6: 173–178.
Adrenal cortex, corticotrophin, corticosteroids and antagonists. In Laurence DR, Benett PN, eds.Clinical Pharmacology, 6th edn. UK; Churchil Livingstone 1987; 647–663.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Khadilkar, V.V., Khadilkar, A.V. & Maskati, G.B. Impact of availability of oral hydrocortisone on growth of children with CAH. Indian J Pediatr 72, 301–303 (2005). https://doi.org/10.1007/BF02724009
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02724009